CLARITEV CORP (CTEV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CTEV - US62548M2098 - Common Stock
49.545 USD
+1.45 (+3%)
CTEV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of CTEV have multiple concerns. CTEV is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CTEV has reported negative net income.
CTEV had a positive operating cash flow in the past year.
In the past 5 years CTEV reported 4 times negative net income.
In the past 5 years CTEV always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CTEV (-13.07%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 1.04%, CTEV is doing good in the industry, outperforming 68.57% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CTEV is below the industry average of 6.67%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.07% | ||
| ROE | N/A | ||
| ROIC | 1.04% |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 6.78%, CTEV is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
In the last couple of years the Operating Margin of CTEV has declined.
CTEV has a Gross Margin of 74.43%. This is in the better half of the industry: CTEV outperforms 77.14% of its industry peers.
CTEV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 74.43% |
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTEV is destroying value.
Compared to 1 year ago, CTEV has about the same amount of shares outstanding.
Compared to 5 years ago, CTEV has less shares outstanding
Compared to 1 year ago, CTEV has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.31, we must say that CTEV is in the distress zone and has some risk of bankruptcy.
CTEV has a Altman-Z score (-0.31) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.31 |
ROIC/WACC0.15
WACC7.01%
2.3 Liquidity
A Current Ratio of 0.98 indicates that CTEV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, CTEV is doing worse than 77.14% of the companies in the same industry.
A Quick Ratio of 0.98 indicates that CTEV may have some problems paying its short term obligations.
With a Quick ratio value of 0.98, CTEV is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
CTEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.52%, which is quite impressive.
CTEV shows a decrease in Revenue. In the last year, the revenue decreased by -3.21%.
CTEV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.09% yearly.
EPS 1Y (TTM)67.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.56%
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%6.71%
3.2 Future
CTEV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.14% yearly.
The Revenue is expected to grow by 3.31% on average over the next years.
EPS Next Y77.63%
EPS Next 2Y35.76%
EPS Next 3Y25.14%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.93%
Revenue Next 3Y3.31%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CTEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTEV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CTEV is valued cheaper than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.68 |
4.3 Compensation for Growth
CTEV's earnings are expected to grow with 25.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.76%
EPS Next 3Y25.14%
5. Dividend
5.1 Amount
No dividends for CTEV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:CTEV (11/25/2025, 11:30:54 AM)
49.545
+1.45 (+3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners40.19%
Inst Owner ChangeN/A
Ins Owners6.91%
Ins Owner Change0.62%
Market Cap818.98M
Revenue(TTM)930.62M
Net Income(TTM)-662.92M
Analysts84.44
Price Target90.1 (81.85%)
Short Float %6.93%
Short Ratio3.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.5%
Min EPS beat(2)-23.58%
Max EPS beat(2)2.57%
EPS beat(4)2
Avg EPS beat(4)-19.98%
Min EPS beat(4)-73.58%
Max EPS beat(4)14.65%
EPS beat(8)5
Avg EPS beat(8)-182.55%
EPS beat(12)6
Avg EPS beat(12)-287.29%
EPS beat(16)8
Avg EPS beat(16)-201.21%
Revenue beat(2)2
Avg Revenue beat(2)2.18%
Min Revenue beat(2)1.86%
Max Revenue beat(2)2.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)2.51%
Revenue beat(8)2
Avg Revenue beat(8)-2.36%
Revenue beat(12)4
Avg Revenue beat(12)-2.64%
Revenue beat(16)6
Avg Revenue beat(16)-2.02%
PT rev (1m)25.59%
PT rev (3m)122.69%
EPS NQ rev (1m)6.21%
EPS NQ rev (3m)1.74%
EPS NY rev (1m)2.97%
EPS NY rev (3m)1.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.88 | ||
| P/FCF | N/A | ||
| P/OCF | 11.57 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.68 |
EPS(TTM)-20.48
EYN/A
EPS(NY)-10.91
Fwd EYN/A
FCF(TTM)-3.32
FCFYN/A
OCF(TTM)4.28
OCFY8.64%
SpS56.6
BVpS-2.41
TBVpS-272.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.07% | ||
| ROE | N/A | ||
| ROCE | 1.32% | ||
| ROIC | 1.04% | ||
| ROICexc | 1.05% | ||
| ROICexgc | 16.44% | ||
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 74.43% | ||
| FCFM | N/A |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
ROICexc(3y)2.48%
ROICexc(5y)N/A
ROICexgc(3y)66.67%
ROICexgc(5y)N/A
ROCE(3y)3.05%
ROCE(5y)N/A
ROICexgc growth 3Y-40.96%
ROICexgc growth 5Y-27.14%
ROICexc growth 3Y-26.84%
ROICexc growth 5Y-14.89%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
F-Score4
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.18 | ||
| Cap/Depr | 28.62% | ||
| Cap/Sales | 13.43% | ||
| Interest Coverage | 0.23 | ||
| Cash Conversion | 14.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | -0.31 |
F-Score4
WACC7.01%
ROIC/WACC0.15
Cap/Depr(3y)25.06%
Cap/Depr(5y)22.79%
Cap/Sales(3y)10.77%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.56%
EPS Next Y77.63%
EPS Next 2Y35.76%
EPS Next 3Y25.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%6.71%
Revenue Next Year1.46%
Revenue Next 2Y2.93%
Revenue Next 3Y3.31%
Revenue Next 5YN/A
EBIT growth 1Y-55.65%
EBIT growth 3Y-37.5%
EBIT growth 5Y-23.25%
EBIT Next Year145.04%
EBIT Next 3Y35.49%
EBIT Next 5YN/A
FCF growth 1Y-151.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.08%
OCF growth 3Y-35.69%
OCF growth 5Y-17.66%
CLARITEV CORP / CTEV FAQ
Can you provide the ChartMill fundamental rating for CLARITEV CORP?
ChartMill assigns a fundamental rating of 2 / 10 to CTEV.
Can you provide the valuation status for CLARITEV CORP?
ChartMill assigns a valuation rating of 1 / 10 to CLARITEV CORP (CTEV). This can be considered as Overvalued.
What is the profitability of CTEV stock?
CLARITEV CORP (CTEV) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for CTEV stock?
The Earnings per Share (EPS) of CLARITEV CORP (CTEV) is expected to grow by 77.63% in the next year.